Hear about what is happening in the pharmaceutical industry, including companies announcing business results, new products and mergers.

Industry News

Added 2 days ago Industry news

Merck Inc., acquires Viralytics and with it Cavatak (CVA 21),investigational oncolytic immunotherapy.

Merck Inc., and Viralytics Limited announced that the companies have signed a definitive agreement under which it is proposed that...

Added 11 days ago Industry news

Allergan to acquire Elastagen Pty Ltd.

Elastagen Pty Ltd, a clinical stage company developing medical device products based on recombinant tropoelastin, announced that it has entered...

Added 15 days ago Industry news

Aviragen Therapeutics to merge with Vaxart Inc.

Aviragen Therapeutics, Inc.and Vaxart, Inc. announced that the companies have agreed to amend the terms of their previously announced merger...

Added 23 days ago Industry news

Seattle Genetics acquires Cascadian Therapeutics and with it tucatinib a tyrosine kinase inhibitor to treat Breast Cancer

Seattle Genetics, Inc.and Cascadian Therapeutics, Inc. announced the signing of a definitive merger agreement under which Seattle Genetics has agreed...

Added 25 days ago Industry news

Sanofi to acquire Ablynx n.v. and with it caplacizumab .

Sanofi and Ablynx, a biopharmaceutical company engaged in the discovery and development of Nanobodies, entered into a definitive agreement under...

Added 1 month ago Industry news

BioCryst Pharmaceuticals, Inc and Idera Pharmaceuticals Inc. to merge.

BioCryst Pharmaceuticals, Inc. and Idera Pharmaceuticals, Inc. announced that they have signed a definitive merger agreement to form a new...

Added 1 month ago Industry news

Sanofi to acquire Bioverativ Inc.

Sanofi and Bioverativ Inc., a biopharmaceutical company focused on therapies for hemophilia and other rare blood disorders, have entered into...

Added 1 month ago Industry news

Celgene acquires Juno Therapeutics and with JCAR 017

Celgene Corporation and Juno Therapeutics, Inc. have announced the signing of a definitive merger agreement.

Added 1 month ago Industry news

Shire plc to operate as two divisions being neuroscience and rare diseases.

In August 2017, Shire announced that it was conducting a strategic review of its neuroscience business. 

Added 1 month ago Industry news

Novo Nordisk proposes acquisition of Ablynx for approximately Euros 2.6 billion which is rejected by Board of Ablynx

Novo Nordisk confirms that it made a proposal on 22 December 2017 to acquire Ablynx for €28.00 per share in...

Search all news articles